- CEO
- Joan Amigo I. Casas
- Full Time Employees
- 27,218
- Sector
- Industrials
- Industry
- Specialty Business Services
- Address
- Parque Empresarial Las Mercedes Madrid Spain 28022
- IPO Date
- Jun 24, 2020
- Business
- Applus Services SA (Applus+), a leading global provider of testing, inspection, and certification (TIC) services, operates through four primary segments: Applus+ Energy & Industry; Applus+ Laboratories; Applus+ Automotive; and Applus+ IDIADA. Applus+ Energy & Industry delivers non-destructive testing, quality accreditation and control, project management, supplier inspection, facility inspection, asset certification and integrity services, and qualified staff recruitment for industries including oil and gas, aircraft, energy, mining, telecommunications, and construction; Applus+ Laboratories provides laboratory testing, system certification, and product development services across aerospace, industrial, and electronic payment systems sectors; Applus+ Automotive conducts mandatory vehicle roadworthiness testing and verifies compliance with safety and emissions regulations; Applus+ IDIADA offers design, engineering, testing, and certification services to automotive manufacturers. The company serves diverse markets such as renewables, infrastructures, conventional power, oil and gas, aerospace, and medical devices, targeting asset owners, manufacturers, governments, and regulatory bodies. Founded in 1996 within the Agbar Group in Barcelona and headquartered in Madrid, Spain, Applus Services employs over 26,000 people and maintains operations in more than 70 countries across Spain, the rest of Europe, the United States, Canada, Asia-Pacific, the Middle East, Africa, and Latin America, with Spain accounting for approximately 23% of revenue. In recent developments, Applus+ signs a definitive agreement in September 2025 to acquire APEM Group (UK) for approximately GBP 335 million, enhancing its laboratories and environmental services capabilities through this platform investment; Applus+ Laboratories completes the acquisition of Notice in Turkey in July 2025, establishing a one-stop-shop for medical device testing, regulatory certification in Europe, and system certification amid the MDR transition.